SBIO ETF (ALPS Medical Breakthroughs ETF) is managed by ALPS Advisors with $213.1M in net assets. SBIO expense ratio is 0.50%, holding 87 positions across sectors including Health Care, Unknown, Other. Inception date: 2014-12-30.

SBIO performance shows a YTD return of 28.38%. The 1-year return is 114.59% and the 5-year return is 6.46%.

SBIO top holdings include Kymera Therapeutics Inccommon Stock (4.2%), Celcuity Inc Common Stock Usd 0.001 (4.1%), Mirum Pharmaceuticals Inc (3.9%), Cg Oncology Inc (3.5%), Alkermes Plc (3.5%). View all SBIO holdings, sector breakdown, or dividend history.

SBIO can be compared against other funds using the overlap calculator or side-by-side comparison tool. SBIO alternatives are available via the screener, along with tax-loss harvesting opportunities.